Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf O Bechstein

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
BMJ Open|January 9, 2021
Study protocol for a prospective, double-blinded, observational study investigating the diagnostic accuracy of an app-based diagnostic health care application in an emergency room setting: the eRadaR trialS Fatima Faqar-Uz-Zaman, Natalie Filmann, Dora Mahkovic, et al.
Annals of Surgery|August 4, 2022
The Diagnostic Efficacy of an App-based Diagnostic Health Care Application in the Emergency Room: eRadaR-Trial. A prospective, Double-blinded, Observational StudySara F Faqar-Uz-Zaman, Luxia Anantharajah, Philipp Baumartz, et al.
Thyroid : Official Journal of the American Thyroid Association|June 9, 2009
Vitamin D receptor polymorphisms in differentiated thyroid carcinomaMarissa Penna-Martinez, Elizabeth Ramos-Lopez, Julienne Stern, et al.
Frontiers in Microbiology|December 9, 2021
Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant CandidatesTilman G Schultze, Philip G Ferstl, David Villinger, et al.
Pleura and Peritoneum|March 27, 2019
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACOThorsten Oliver Goetze, Salah-Eddin Al-Batran, Urs Pabst, et al.
Transplantation Direct|July 15, 2021
Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND StudyStyrbjörn Friman, Giuseppe Tisone, Frederik Nevens, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2022
Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinomaMaximilian N Kinzler, Angelika Stehle, Falko Schulze, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomasChristoph Renné, Elizabeth Ramos Lopez, Susanne A Steimle-Grauer, et al.
BMC Cancer|October 30, 2021
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACOThorsten O Götze, Pompiliu Piso, Sylvie Lorenzen, et al.
Journal of Hepatocellular Carcinoma|May 25, 2026
The Prognostic Value of Circulating Stem Cells Expressing PD-L1 in Patients with Hepatocellular CarcinomaDhruvajyoti Roy, Elsie Oppermann, Thomas J Vogl, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
BMJ Open|January 9, 2021
Study protocol for a prospective, double-blinded, observational study investigating the diagnostic accuracy of an app-based diagnostic health care application in an emergency room setting: the eRadaR trialS Fatima Faqar-Uz-Zaman, Natalie Filmann, Dora Mahkovic, et al.
Annals of Surgery|August 4, 2022
The Diagnostic Efficacy of an App-based Diagnostic Health Care Application in the Emergency Room: eRadaR-Trial. A prospective, Double-blinded, Observational StudySara F Faqar-Uz-Zaman, Luxia Anantharajah, Philipp Baumartz, et al.
Thyroid : Official Journal of the American Thyroid Association|June 9, 2009
Vitamin D receptor polymorphisms in differentiated thyroid carcinomaMarissa Penna-Martinez, Elizabeth Ramos-Lopez, Julienne Stern, et al.
Frontiers in Microbiology|December 9, 2021
Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant CandidatesTilman G Schultze, Philip G Ferstl, David Villinger, et al.
Pleura and Peritoneum|March 27, 2019
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACOThorsten Oliver Goetze, Salah-Eddin Al-Batran, Urs Pabst, et al.
Transplantation Direct|July 15, 2021
Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND StudyStyrbjörn Friman, Giuseppe Tisone, Frederik Nevens, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2022
Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinomaMaximilian N Kinzler, Angelika Stehle, Falko Schulze, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomasChristoph Renné, Elizabeth Ramos Lopez, Susanne A Steimle-Grauer, et al.
BMC Cancer|October 30, 2021
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACOThorsten O Götze, Pompiliu Piso, Sylvie Lorenzen, et al.
Journal of Hepatocellular Carcinoma|May 25, 2026
The Prognostic Value of Circulating Stem Cells Expressing PD-L1 in Patients with Hepatocellular CarcinomaDhruvajyoti Roy, Elsie Oppermann, Thomas J Vogl, et al.
Pageof 15